Poland· PL-100386210
Kreon 35 000
A multienzyme - lipase, protease etc product containing pancreatinum, registered in Poland by Viatris Healthcare Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Multienzyme - lipase, protease etc is registered in 11 of 19 countries.
Countries holding a registration under ATC A09AA02 (multienzyme - lipase, protease etc), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Multienzyme - lipase, protease etc · ATC A09AA02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Pancreatinum
- Manufacturer
- Viatris Healthcare Limited
- Country
- Poland (PL)
- ATC code
- A09AA02
- ATC class
- Multienzyme - Lipase, Protease etc
- Defined daily dose
- 240 TSD, FIP
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 5
- gtin05901797710286
- gtin05901797710293
- gtin05901797710309
- gtin05901797710316
- gtin05901797710323
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
20 interactions on record for multienzyme - lipase, protease etc.
Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Multienzyme - lipase, protease etc · interactions on record
20 records
- 20 moderate
Most severe, free to view
- Magnesium hydroxideA02AA04moderate
- Kombinationen von AluminiumsalzenA02AB10moderate
- Calcium carbonateA02AC01moderate
- MagaldrateA02AD02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Multienzyme - lipase, protease etc in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKREONVIATRIS HEALTHCARE LIMITED, Dublin
- FinlandCreon 10 000Oy Cross Pharma Ab
- IrelandCreon 10000 Gastro-resistant CapsulesViatris Healthcare Limited
- SwitzerlandCreon 10000
- GermanyKreonViatris Healthcare Gmbh
- NorwayCreon 10000Viatris AS
- FranceEUROBIOL 12 500 U, gélule gastrorésistanteLABORATOIRES MAYOLY SPINDLER
- BelgiumEnzepi 10000 UAptalis Pharma
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Kreon, Kreon – Kapseln
- Belgium · Ankreta, Creon
- Bulgaria · Креон
- Cyprus · Creon
- Czechia · Kreon, Pancreolan Forte 6000
- Germany · Kreon, Pancrin
- Denmark · Creon
- Estonia · Kreon, Mezym
- Spain · Kreon
- Finland · Creon, Micrazym
- France · Creon
- United Kingdom (Northern Ireland) · Creon, Creon Micro
- Greece · Creon, Creon-P
- Croatia · Kreon, Pangrol
- Hungary · Dipankrin Optimum, Kreon
- Ireland · Creon, Creon For Children
- Iceland · Creon
- Italy · Creon, Creonipe
- Lithuania · Kreon, Pangrol
- Luxembourg · Ankreta, Creon
- Latvia · Kreon, Pangrol
- Malta · Creon
- Netherlands · Creon, Micrazym
- Norway · Creon
- Portugal · Kreon, Kreon 25000
- Romania · Kreon, Mezym
- Sweden · Creon, Micrazym
- Slovenia · Kreon, Kreon Epi
- Slovakia · Kreon, Pancreolan Forte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc43fd12-7114-432f-a5dc-3709d19c1978 GET /v1/drugs/dc43fd12-7114-432f-a5dc-3709d19c1978?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki dojelitowe, twarde",
"source": "urpl",
"strength": "35000 Ph.Eur.U. aktywności lipolitycznej",
"packaging": "05901797710286 ¦ Rp ¦ 130968\n50 kaps.\n05901797710293 ¦ Rp ¦ 130969\n60 kaps.\n05901797710309 ¦ Rp ¦ 130970\n100 kaps.\n05901797710316 ¦ Rp ¦ 130971\n120 kaps.\n05901797710323 ¦ Rp ¦ 130972\n200 kaps.",
"substance": "Pancreatinum 35000 IU",
"common_name": "Pancreatinum",
"pl_product_id": "100386210",
"pozwolenie_nr": "25110",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about multienzyme - lipase, protease etc.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.